Keywords: pfizer, recovers, patent, expiry, slump, strong, international
Pfizer recovers from patent expiry slump with strong international sales in 2nd qtr
Article | 04 August 2008
Global pharmaceutical giant Pfizer more than doubled its second-quarter 2008 profit, recovering from a poor first quarter (Marketletter April 28), due to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
